Pien Tze Huang suppresses the stem-like side population in colorectal cancer cells

被引:38
|
作者
Wei, Lihui [1 ,2 ]
Chen, Pangyu [1 ,2 ]
Chen, Youqin [3 ]
Shen, Aling [1 ,2 ]
Chen, Hongwei [1 ,2 ]
Lin, Wei [1 ,2 ]
Hong, Zhenfeng [1 ]
Sferra, Thomas J. [3 ]
Peng, Jun [1 ,2 ,4 ]
机构
[1] Fujian Univ Tradit Chinese Med, Acad Integrat Med, Fuzhou 350122, Fujian, Peoples R China
[2] Fujian Univ Tradit Chinese Med, Fujian Key Lab Integrat Med Geriatr, Fuzhou 350122, Fujian, Peoples R China
[3] Case Western Reserve Univ, Sch Med, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA
[4] Zhangzhou Pien Tze Huang Pharmaceut Co Ltd, Postdoctor Workstn, Zhangzhou 363000, Fujian, Peoples R China
基金
中国博士后科学基金;
关键词
Pien Tze Huang; traditional Chinese medicine; colorectal cancer; cancer stem cells; side population; ACUTE MYELOID-LEUKEMIA; COLON-CARCINOMA CELLS; NATURAL-PRODUCTS; PROLIFERATION; ANGIOGENESIS; ACTIVATION; APOPTOSIS; PATHWAY; FAMILY; LINES;
D O I
10.3892/mmr.2013.1760
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Accumulating evidence suggests that a small population of cells termed cancer stem cells (CSCs) are crucial in tumor development and drug resistance, leading to cancer relapse and metastasis and eventually the failure of clinical cancer treatment. Therefore, targeting CSCs is a promising approach for anticancer therapies. Due to the drug resistance and adverse effects of currently used chemotherapies, traditional Chinese medicines (TCM) have recently received attention due to the relatively few side-effects. Thus, they have been used as important alternative remedies for various diseases, including cancer. Pien Tze Huang (PZH), a well-known TCM formula that was first prescribed more than 450 years ago in the Ming Dynasty, has been used in China and Southeast Asia for centuries as a folk remedy for various types of cancer. Previously, it was reported that PZH inhibits colon cancer growth via the promotion of cancer cell apoptosis and inhibition of cell proliferation and tumor angiogenesis, which is probably mediated by its regulatory effect on multiple intracellular signaling pathways. To elucidate the mechanism of the tumoricidal activity of PZH, the aim of the present study was to investigate the effect of PZH on CSCs that were isolated as the side population (SP) from the HT-29 colorectal cancer cell line. The results demonstrated that PZH significantly and dose-dependently reduced the percentage of the colorectal cancer stem-like SP cells, decreased the viability and sphere-forming capacity of HT-29 SP cells, indicating that PZH is potent in suppressing the growth of colorectal cancer stem cells. Moreover, PZH treatment in HT-29 SP cells markedly inhibited the mRNA levels of ABCB1 and ABCG2, which are members of the ABC transporter superfamily, thereby contributing to the SP phenotype and multi-drug resistance. Findings of the present study suggest that inhibiting the growth of CSCs is a potential mechanism by which PZH can be used in cancer treatment.
引用
收藏
页码:261 / 266
页数:6
相关论文
共 50 条
  • [31] Therapeutic potential of Pien Tze Huang in colitis-associated colorectal cancer: mechanistic insights from a mouse model
    Liu, Liya
    Chen, Youqin
    Liu, Sijia
    Zhang, Xinran
    Cao, Liujing
    Wu, Yulun
    Han, Yuying
    Lin, Guosheng
    Wei, Lihui
    Fang, Yi
    Sferra, Thomas J.
    Jafri, Anjum
    Liu, Huixin
    Li, Li
    Shen, Aling
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
  • [32] Pien Tze Huang inhibits tumor angiogenesis in a mouse model of colorectal cancer via suppression of multiple cellular pathways
    Shen, Aling
    Lin, Jiumao
    Chen, Youqin
    Lin, Wei
    Liu, Liya
    Hong, Zhenfeng
    Sferra, Thomas J.
    Peng, Jun
    ONCOLOGY REPORTS, 2013, 30 (04) : 1701 - 1706
  • [33] Distinct Radiosensitivity of Lung Carcinoma Stem-Like Side Population and Main Population Cells
    Xia, Pu
    Gou, Wen-feng
    Wang, Jin-jin
    Niu, Ze-feng
    Chen, Shuo
    Takano, Yasuo
    Zheng, Hua-chuan
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2013, 28 (06) : 471 - 478
  • [34] ANRIL promotes the regulation of colorectal cancer on lymphatic endothelial cells via VEGF-C and is the key target for Pien Tze Huang to inhibit cancer metastasis
    Bin Huang
    Yao Lu
    Zhuona Ni
    Jinhong Liu
    Yanbin He
    Honglin An
    Feimin Ye
    Jiayu Shen
    Minghe Lin
    Yong Chen
    Jiumao Lin
    Cancer Gene Therapy, 2023, 30 : 1260 - 1273
  • [35] Characterization of side population in thyroid cancer cell lines: Cancer stem-like cells are enriched partly but not exclusively
    Mitsutake, Norisato
    Iwao, Atsuhiko
    Nagai, Kazuhiro
    Namba, Hiroyuki
    Ohtsuru, Akira
    Saenko, Vladimir
    Yamashita, Shunichi
    ENDOCRINOLOGY, 2007, 148 (04) : 1797 - 1803
  • [36] Identification of Cancer Stem-like Side Population Cells in Ovarian Cancer Cell Line OVCAR-3
    Gao, Quanli
    Geng, Li
    Kvalheim, Gunnar
    Gaudernack, Gustav
    Suo, Zhenhe
    ULTRASTRUCTURAL PATHOLOGY, 2009, 33 (04) : 175 - 181
  • [37] Berberine Suppresses Stemness and Tumorigenicity of Colorectal Cancer Stem-Like Cells by Inhibiting m6A Methylation
    Zhao, Ziyi
    Zeng, Jinhao
    Guo, Qiang
    Pu, Kunming
    Yang, Yi
    Chen, Nianzhi
    Zhang, Gang
    Zhao, Maoyuan
    Zheng, Qiao
    Tang, Jianyuan
    Hu, Qiongying
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [38] The Side Story of Stem-like Glioma Cells
    Persson, Anders I.
    Weiss, William A.
    CELL STEM CELL, 2009, 4 (03) : 191 - 192
  • [39] PIEN TZE HUANG PREVENTS COLORECTAL TUMORIGENESIS IN MICE THROUGH MODULATING GUT MICROBIOTA AND RELATED METABOLITES
    Gou, Hongyan
    Su, Hao
    Zeng, Xianyi
    Huang, Ziheng
    Li, Yan
    Zhou, Yunfei
    Chen, Huarong
    Wong, Chi Chun
    Yu, Jun
    GASTROENTEROLOGY, 2022, 162 (07) : S452 - S452
  • [40] ANRIL promotes the regulation of colorectal cancer on lymphatic endothelial cells via VEGF-C and is the key target for Pien Tze Huang to inhibit cancer metastasis
    Huang, Bin
    Lu, Yao
    Ni, Zhuona
    Liu, Jinhong
    He, Yanbin
    An, Honglin
    Ye, Feimin
    Shen, Jiayu
    Lin, Minghe
    Chen, Yong
    Lin, Jiumao
    CANCER GENE THERAPY, 2023, 30 (09) : 1260 - 1273